Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology
|
September 12, 2002
Detection of procathepsin D in rat milk
P Benes, G Koelsch, B Dvorak, et al.
Developmental and Comparative Immunology
|
January 1, 1988
Influence of interferon gamma on B cell replication
V Vetvicka, G Lee, G L Spitalny, et al.
International Journal of Cancer
|
November 14, 1997
Analysis of the interaction of procathepsin D activation peptide with breast cancer cells
V Vetvicka, J Vetvickova, I Hilgert, et al.
Immunopharmacology
|
July 17, 1999
Therapeutic intervention with complement and beta-glucan in cancer
G D Ross, V Vetvicka, J Yan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 15, 1997
Targeting of natural killer cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and beta-glucan-primed CR3 (CD11b/CD18)
V Vetvicka, B P Thornton, T J Wieman, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 11, 1999
The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells
Y Xia, V Vetvicka, J Yan, et al.
Biomaterials
|
July 1, 1989
Biocompatibility of N-(2-hydroxypropyl) methacrylamide copolymers containing adriamycin. Immunogenicity, and effect on haematopoietic stem cells in bone marrow in vivo and mouse splenocytes and human peripheral blood lymphocytes in vitro
B Rihova, M Bilej, V Vetvicka, et al.
Immunopharmacology
|
February 9, 2000
Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonized erythrocytes or soluble beta-glucan
J Yan, V Vetvicka, Y Xia, et al.
Immunobiology
|
August 1, 1986
Biochemical characterization of Fc gamma receptors of mouse DCH-5 cell line
J Zikan, L Fornusek, V Vetvicka, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 8, 1999
Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18)
J Yan, V Vetvicka, Y Xia, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology
|
September 12, 2002
Detection of procathepsin D in rat milk
P Benes, G Koelsch, B Dvorak, et al.
Developmental and Comparative Immunology
|
January 1, 1988
Influence of interferon gamma on B cell replication
V Vetvicka, G Lee, G L Spitalny, et al.
International Journal of Cancer
|
November 14, 1997
Analysis of the interaction of procathepsin D activation peptide with breast cancer cells
V Vetvicka, J Vetvickova, I Hilgert, et al.
Immunopharmacology
|
July 17, 1999
Therapeutic intervention with complement and beta-glucan in cancer
G D Ross, V Vetvicka, J Yan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 15, 1997
Targeting of natural killer cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and beta-glucan-primed CR3 (CD11b/CD18)
V Vetvicka, B P Thornton, T J Wieman, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 11, 1999
The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells
Y Xia, V Vetvicka, J Yan, et al.
Biomaterials
|
July 1, 1989
Biocompatibility of N-(2-hydroxypropyl) methacrylamide copolymers containing adriamycin. Immunogenicity, and effect on haematopoietic stem cells in bone marrow in vivo and mouse splenocytes and human peripheral blood lymphocytes in vitro
B Rihova, M Bilej, V Vetvicka, et al.
Immunopharmacology
|
February 9, 2000
Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonized erythrocytes or soluble beta-glucan
J Yan, V Vetvicka, Y Xia, et al.
Immunobiology
|
August 1, 1986
Biochemical characterization of Fc gamma receptors of mouse DCH-5 cell line
J Zikan, L Fornusek, V Vetvicka, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 8, 1999
Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18)
J Yan, V Vetvicka, Y Xia, et al.
Page
of 4